Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK

PURPOSE: Treatment guidance for chronic obstructive pulmonary disease (COPD) recommends inhaled corticosteroid (ICS)+long-acting muscarinic antagonist+long-acting β(2)-agonist (LABA) triple therapy for patients who experience recurrent exacerbations, persistent breathlessness, or exercise limitation...

Descripción completa

Detalles Bibliográficos
Autores principales: Quint, Jennifer K, Venerus, Alessandra, O’Leary, Caroline, Myland, Melissa, Holmgren, Ulf, Varghese, Precil, Cabrera, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733404/
https://www.ncbi.nlm.nih.gov/pubmed/33324049
http://dx.doi.org/10.2147/COPD.S278101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733404/
https://www.ncbi.nlm.nih.gov/pubmed/33324049
http://dx.doi.org/10.2147/COPD.S278101

Ejemplares similares